Congress Trades in West Pharmaceutical Services, Inc. (WST)
7 members of Congress have disclosed trading WST.
Total trades
10
Purchases
7
Sales
3
Members
7
Est. volume
$147,000
Last traded
Jun 17, 2025
Want the fundamentals on WST?
WST stock analysis →
See West Pharmaceutical Services, Inc.'s price, P/E, ROE and a free return calculator.
7 members of Congress have disclosed trading West Pharmaceutical Services, Inc. (WST), with 10 transactions in total — 7 purchases and 3 sales worth an estimated $147,000 at range midpoints, leaning heavily toward buying. The most active WST trader is Jared Moskowitz (3 disclosures). The most recent disclosed WST trade was on Jun 17, 2025. See our full WST fundamentals page for price, valuation and a return calculator.
Every disclosed WST trade
| Disclosed | Politician | Type | Amount | Traded | |
|---|---|---|---|---|---|
| Aug 13, 2025 | Lisa McClain R | Purchase | $1,001 - $15,000 | Jun 17, 2025 | filing ↗ |
| Feb 28, 2025 | Jared Moskowitz D | Sale | $1,001 - $15,000 | Feb 13, 2025 | filing ↗ |
| Feb 25, 2025 | Rob Bresnahan | Purchase | $1,001 - $15,000 | Feb 25, 2025 | filing ↗ |
| Aug 12, 2024 | Jared Moskowitz D | Purchase | $1,001 - $15,000 | Dec 28, 2023 | filing ↗ |
| Dec 31, 2023 | Jared Moskowitz D | Purchase | $1,001 - $15,000 | Dec 28, 2023 | filing ↗ |
| Jun 30, 2019 | Donna Shalala | Sale | $1,001 - $15,000 | Jun 24, 2019 | filing ↗ |
| Oct 1, 2018 | Greg Gianforte | Purchase | $50,001 - $100,000 | Sep 25, 2018 | filing ↗ |
| Sep 25, 2018 | Josh Gottheimer D | Sale | $1,001 - $15,000 | Jan 24, 2018 | filing ↗ |
| May 7, 2018 | Lamar Smith | Purchase | $1,001 - $15,000 | Apr 30, 2018 | filing ↗ |
| Feb 1, 2018 | Lamar Smith | Purchase | $1,001 - $15,000 | Jan 18, 2018 | filing ↗ |
Most active WST traders in Congress
Jared Moskowitz
Democrat
3 trades
LS
Lamar Smith
2 trades
Lisa McClain
Republican
1 trade
RB
Rob Bresnahan
1 trade
DS
Donna Shalala
1 trade
GG
Greg Gianforte
1 trade
Josh Gottheimer
Democrat
1 trade
Source: US House Clerk Periodic Transaction Reports. Amounts are disclosed as ranges; estimates use range midpoints. Data may be delayed or contain filer errors. Not investment advice.